US Stock Surge: Hasbro Soars on October 5th Due to Transocean Acquisition and End of Review
Bitget异动解读2026/10/05 15:00Hanshibo October 5th Surge Analysis
Keywords: Transocean acquisition, review completed
On September 30th, Hanshibo and Transocean received notification from the US Department of Justice Antitrust Division that the relevant antitrust review has concluded, and the HSR Act waiting period has expired. Both parties currently expect the transaction to be completed in the fourth quarter of 2026, but it is still subject to the fulfillment or waiver of remaining closing conditions.
(Disclaimer: This content is summarized from publicly available information using AI technology and is for reference only, not investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like



Amgen (AMGN.US) and AstraZeneca (AZN.US) combination therapy extends small cell lung cancer survival by eight months, reduces risk of death by 58%
Researchers combined Amgen's Imdelltra with AstraZeneca's Imfinzi and found that for patients with aggressive lung cancer whose tumors had already spread, this combination extended survival by about eight months compared to Imfinzi monotherapy. Small cell lung cancer is one of the cancer types with the worst prognosis.
